Dec 13, 2022

You may have heard about erythrodermic psoriasis but just what is it? Dr. Mio Nakamura from the University of Michigan, Dept. of Dermatology answers questions about this serious and potentially life-threatening form of psoriasis from types, symptoms, need for acute care, to potential triggers, treatment options and risk...

Dec 6, 2022

Have questions about JAK inhibitors? Not sure how they work, what they treat, risks and how effective they are compared to other treatments? Listen as rheumatologist and NPF Medical Board member, Dr. Sergio Schwartzman from Weill Cornell Medical Center in NY, addresses such questions and more about the JAK STAT pathway....

Nov 29, 2022

Topical therapies are a mainstay of psoriasis care but can be challenging to use. Hear what challenges they present and how the latest topicals - Tapinarof and Roflumilast could revolutionize topical treatments from dermatologist and NPF Medical Board member, Dr. Larry Green, Aesthetics and Dermatology Center in...

Nov 15, 2022

Join dermatologist Dr. Jason Hawkes, Associate Professor of Dermatology at the University of California, Davis, as he breaks down the immune pathways and feed forward mechanism driving the development of psoriasis and psoriatic arthritis, and why the IL-17/IL-23 axis is key to the development of targeted treatments for...

Nov 3, 2022

Treatment options backed by real-world evidence means more opportunities for those living with moderate-to-severe plaque psoriasis. Join Steve Rozzo, Ph.D., Sun Pharma, and Neal Bhatia, M.D., Therapeutics Clinical Research in San Diego, CA in a Q&A discussion on real-world clinical data of ILUMYA® and what the findings...